Literature DB >> 21821793

Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors.

Hiroshi Ban1, Naoki Nishishita, Noemi Fusaki, Toshiaki Tabata, Koichi Saeki, Masayuki Shikamura, Nozomi Takada, Makoto Inoue, Mamoru Hasegawa, Shin Kawamata, Shin-Ichi Nishikawa.   

Abstract

After the first report of induced pluripotent stem cells (iPSCs), considerable efforts have been made to develop more efficient methods for generating iPSCs without foreign gene insertions. Here we show that Sendai virus vector, an RNA virus vector that carries no risk of integrating into the host genome, is a practical solution for the efficient generation of safer iPSCs. We improved the Sendai virus vectors by introducing temperature-sensitive mutations so that the vectors could be easily removed at nonpermissive temperatures. Using these vectors enabled the efficient production of viral/factor-free iPSCs from both human fibroblasts and CD34(+) cord blood cells. Temperature-shift treatment was more effective in eliminating remaining viral vector-related genes. The resulting iPSCs expressed human embryonic stem cell markers and exhibited pluripotency. We suggest that generation of transgene-free iPSCs from cord blood cells should be an important step in providing allogeneic iPSC-derived therapy in the future.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821793      PMCID: PMC3161531          DOI: 10.1073/pnas.1103509108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Dissection of individual functions of the Sendai virus phosphoprotein in transcription.

Authors:  M C Bowman; S Smallwood; S A Moyer
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.

Authors:  H Kawasaki; K Mizuseki; S Nishikawa; S Kaneko; Y Kuwana; S Nakanishi; S I Nishikawa; Y Sasai
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

3.  Efficient differentiation of human embryonic stem cells to definitive endoderm.

Authors:  Kevin A D'Amour; Alan D Agulnick; Susan Eliazer; Olivia G Kelly; Evert Kroon; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2005-10-28       Impact factor: 54.908

4.  Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.

Authors:  Kejin Hu; Junying Yu; Kran Suknuntha; Shulan Tian; Karen Montgomery; Kyung-Dal Choi; Ron Stewart; James A Thomson; Igor I Slukvin
Journal:  Blood       Date:  2011-02-04       Impact factor: 22.113

5.  Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins.

Authors:  Makoto Inoue; Yumiko Tokusumi; Hiroshi Ban; Takumi Kanaya; Tsuyoshi Tokusumi; Yoshiyuki Nagai; Akihiro Iida; Mamoru Hasegawa
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression.

Authors:  H O Li; Y F Zhu; M Asakawa; H Kuma; T Hirata; Y Ueda; Y S Lee; M Fukumura; A Iida; A Kato; Y Nagai; M Hasegawa
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells.

Authors:  Xi-Min Guo; Yun-Shan Zhao; Hai-Xia Chang; Chang-Yong Wang; Ling-Ling E; Xiao-Ai Zhang; Cui-Mi Duan; Ling-Zhi Dong; Hong Jiang; Jing Li; Ying Song; Xiangzhong Jerry Yang
Journal:  Circulation       Date:  2006-05-01       Impact factor: 29.690

8.  Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells.

Authors:  C H Jin; K Kusuhara; Y Yonemitsu; A Nomura; S Okano; H Takeshita; M Hasegawa; K Sueishi; T Hara
Journal:  Gene Ther       Date:  2003-02       Impact factor: 5.250

9.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

10.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

View more
  204 in total

Review 1.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Non-viral iPSCs: a safe way for therapy?

Authors:  Weiqi Zhang; Di Guan; Jing Qu; Weizhou Zhang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2012-04       Impact factor: 14.870

Review 3.  Hepatocyte Transplantation: Quo Vadis?

Authors:  Mark Barahman; Patrik Asp; Namita Roy-Chowdhury; Milan Kinkhabwala; Jayanta Roy-Chowdhury; Rafi Kabarriti; Chandan Guha
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-29       Impact factor: 7.038

4.  Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non-Integrating Viral Reprogramming Vector.

Authors:  Arun Sharma; Michael Mücke; Christine E Seidman
Journal:  Curr Protoc Mol Biol       Date:  2018-04

5.  Rhesus Macaque iPSC Generation and Maintenance.

Authors:  Ravi Chandra Yada; So Gun Hong; Yongshun Lin; Thomas Winkler; Cynthia E Dunbar
Journal:  Curr Protoc Stem Cell Biol       Date:  2017-05-16

6.  Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Keiichi Fukuda; Noemi Fusaki; Akihiro Iida; Mamoru Hasegawa; Alexander Lichtler; Ernst J Reichenberger
Journal:  Cell Reprogram       Date:  2013-11-12       Impact factor: 1.987

7.  Reprogramming human fibroblasts to pluripotency using modified mRNA.

Authors:  Pankaj K Mandal; Derrick J Rossi
Journal:  Nat Protoc       Date:  2013-02-21       Impact factor: 13.491

8.  Pathogenic Tau Impairs Axon Initial Segment Plasticity and Excitability Homeostasis.

Authors:  Peter Dongmin Sohn; Cindy Tzu-Ling Huang; Rui Yan; Li Fan; Tara E Tracy; Carolina M Camargo; Kelly M Montgomery; Taylor Arhar; Sue-Ann Mok; Rebecca Freilich; Justin Baik; Manni He; Shiaoching Gong; Erik D Roberson; Celeste M Karch; Jason E Gestwicki; Ke Xu; Kenneth S Kosik; Li Gan
Journal:  Neuron       Date:  2019-09-18       Impact factor: 17.173

9.  Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.

Authors:  Leelamma M Panicker; Diana Miller; Ola Awad; Vivek Bose; Yu Lun; Tea Soon Park; Elias T Zambidis; Judi A Sgambato; Ricardo A Feldman
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

10.  Selection via pluripotency-related transcriptional screen minimizes the influence of somatic origin on iPSC differentiation propensity.

Authors:  Katherine A Hartjes; Xing Li; Almudena Martinez-Fernandez; Alexa J Roemmich; Brandon T Larsen; Andre Terzic; Timothy J Nelson
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.